Nath Bio-Genes (India) Ltd
Nath Bio-Genes (India) is engaged in the business of Production, Processing, and Marketing of Hybrid and GM Seeds.
- Market Cap ₹ 505 Cr.
- Current Price ₹ 266
- High / Low ₹ 416 / 126
- Stock P/E 8.99
- Book Value ₹ 317
- Dividend Yield 0.00 %
- ROCE 9.24 %
- ROE 9.47 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 0.84 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Tax rate seems low
- Company has a low return on equity of 8.40% for last 3 years.
- Promoters have pledged 40.09% of their holding.
- Company has high debtors of 158.60 days.
- Promoter holding has decreased over last 3 years: -6.44%
Peer comparison
Sector: Miscellaneous Industry: Miscellaneous
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
50.82 | 126.96 | 24.60 | 28.27 | 52.73 | 165.95 | 21.68 | 33.44 | 60.64 | 193.65 | 23.71 | 36.96 | |
46.38 | 99.63 | 18.64 | 21.91 | 46.51 | 128.40 | 16.01 | 27.37 | 53.43 | 149.45 | 17.86 | 29.65 | |
Operating Profit | 4.44 | 27.33 | 5.96 | 6.36 | 6.22 | 37.55 | 5.67 | 6.07 | 7.21 | 44.20 | 5.85 | 7.31 |
OPM % | 8.74% | 21.53% | 24.23% | 22.50% | 11.80% | 22.63% | 26.15% | 18.15% | 11.89% | 22.82% | 24.67% | 19.78% |
Other Income | -0.14 | 0.65 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest | 2.05 | 1.12 | 2.00 | 1.74 | 1.35 | 1.73 | 1.49 | 1.63 | 1.69 | 1.98 | 2.01 | 2.10 |
Depreciation | 0.20 | 0.35 | 0.35 | 0.35 | 0.40 | 0.35 | 0.38 | 0.38 | 0.35 | 0.67 | 0.67 | 0.67 |
Profit before tax | 2.05 | 26.51 | 3.61 | 4.27 | 4.47 | 35.47 | 3.80 | 4.06 | 5.17 | 41.55 | 3.17 | 4.54 |
Tax % | 15.12% | 1.89% | 0.00% | 18.03% | -22.82% | 0.59% | 2.89% | 3.94% | -47.58% | 0.70% | 4.73% | 6.39% |
Net Profit | 1.74 | 26.01 | 3.61 | 3.50 | 5.50 | 35.26 | 3.69 | 3.90 | 7.63 | 41.26 | 3.01 | 4.25 |
EPS in Rs | 0.92 | 13.69 | 1.90 | 1.84 | 2.89 | 18.55 | 1.94 | 2.05 | 4.01 | 21.71 | 1.58 | 2.24 |
Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes |
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
72 | 80 | 97 | 109 | 136 | 143 | 127 | 142 | 171 | 206 | 246 | 315 | |
63 | 67 | 82 | 89 | 102 | 109 | 103 | 113 | 131 | 163 | 191 | 250 | |
Operating Profit | 9 | 13 | 15 | 20 | 34 | 35 | 25 | 29 | 40 | 43 | 55 | 65 |
OPM % | 13% | 17% | 15% | 18% | 25% | 24% | 19% | 20% | 24% | 21% | 22% | 20% |
Other Income | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 0 |
Interest | 2 | 2 | 2 | 4 | 4 | 5 | 6 | 10 | 10 | 5 | 7 | 8 |
Depreciation | 5 | 5 | 5 | 5 | 5 | 4 | 4 | 3 | 1 | 1 | 1 | 2 |
Profit before tax | 2 | 8 | 9 | 12 | 26 | 26 | 15 | 17 | 30 | 39 | 49 | 54 |
Tax % | -4% | -4% | -1% | 4% | 5% | 4% | 6% | 3% | 2% | 1% | -4% | |
Net Profit | 2 | 8 | 9 | 12 | 24 | 25 | 14 | 16 | 29 | 38 | 50 | 56 |
EPS in Rs | 3.62 | 12.37 | 5.75 | 7.34 | 15.18 | 15.87 | 8.85 | 10.17 | 15.48 | 20.22 | 26.56 | 29.54 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | 13% |
5 Years: | 11% |
3 Years: | 20% |
TTM: | 15% |
Compounded Profit Growth | |
---|---|
10 Years: | 36% |
5 Years: | 15% |
3 Years: | 46% |
TTM: | 16% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 29% |
3 Years: | -18% |
1 Year: | -16% |
Return on Equity | |
---|---|
10 Years: | 11% |
5 Years: | 9% |
3 Years: | 8% |
Last Year: | 9% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Sep 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
6 | 6 | 16 | 16 | 16 | 16 | 16 | 16 | 19 | 19 | 19 | 19 | |
Reserves | 13 | 21 | 30 | 41 | 66 | 91 | 105 | 287 | 450 | 489 | 539 | 583 |
Borrowings | 21 | 14 | 11 | 19 | 23 | 22 | 59 | 74 | 33 | 58 | 70 | 79 |
70 | 62 | 63 | 67 | 85 | 97 | 87 | 78 | 69 | 80 | 102 | 30 | |
Total Liabilities | 110 | 102 | 120 | 143 | 190 | 226 | 267 | 455 | 571 | 646 | 730 | 711 |
27 | 23 | 21 | 18 | 17 | 13 | 30 | 207 | 211 | 232 | 246 | 245 | |
CWIP | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | 0 | 0 | 1 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
82 | 78 | 99 | 120 | 168 | 208 | 231 | 243 | 355 | 409 | 479 | 461 | |
Total Assets | 110 | 102 | 120 | 143 | 190 | 226 | 267 | 455 | 571 | 646 | 730 | 711 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|
15 | 6 | -14 | 3 | -47 | -23 | 9 | |||||
-16 | -2 | -17 | -4 | -4 | -20 | -14 | |||||
1 | -4 | 30 | 5 | 90 | 20 | 6 | |||||
Net Cash Flow | -0 | -1 | -0 | 5 | 39 | -23 | 1 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|
ROCE % | 24% | 22% | 24% | 33% | 26% | 14% | 10% | 9% | 8% | 9% | |
Debtor Days | 33 | 35 | 47 | 70 | 95 | 114 | 130 | 133 | 175 | 191 | 159 |
Inventory Turnover | 0.14 | 0.64 | -0.02 | 0.01 | -0.25 | -0.15 | 0.10 | 0.08 | -0.17 | -0.22 |
Documents
Add documentRecent announcements
- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. 19 Feb
- Announcement under Regulation 30 (LODR)-Earnings Call Transcript 17 Feb
- Announcement under Regulation 30 (LODR)-Investor Presentation 12 Feb
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 11 Feb
- Outcome Of Board Meeting 10 Feb
View all